Sonjaya S Gaur

Clinical Professor

Marketing and Public Relations

  • MS, Birla Institute of Technology and Science Pilani
  • B. Eng, Birla Institute of Technology and Science Pilani
  • MPhil, Birla Institute of Technology and Science Pilani
  • PHD, Birla Institute of Technology and Science Pilani
Contact Info

Dr. Sanjaya Singh Gaur is currently a Clinical Professor of Marketing at the NYU School of Professional Studies. He has over 25 years of academic career in USA, Malaysia, New Zealand, Germany, Sweden, South Korea, and India. Prior to joining NYU, Dr. Gaur held appointments at the Sunway University Business School, Malaysia, Auckland University of Technology, New Zealand, Indian Institute of Technology (IIT), Bombay, and SP Jain Institute of Management and Research (SPJIMR), Bombay.

While teaching is Dr. Gaur’s passion, he has also made important contributions to research. He is an Associate Editor at the Journal of Asia Business Studies and a member of the editorial board for several leading journals including Journal of Business Research and Journal of World Business. His research spans across micro and macro levels. At the micro level, his research is in the broad domain of behavioral research involving socio-psychological constructs such as human emotions, decision making, social identity, ethics, and action. This work has been applied to the study of consumers, salespersons, managers, patients, doctors, and organizations. At the macro level, he has examined how firm level issues such as market orientation, governance, CSR, inter-organizational trust and top management team characteristics affect the strategies and performance of firms in different geographical settings. The research settings in his empirical work include Malaysia, UAE, India, Bangladesh, China, Germany, and New Zealand. He has received several “best paper” awards for his research including three from the American Marketing Association in 2017, 2019, and 2020.

Dr. Gaur has consulted many multinational corporations including GlaxoSmithKline (GSK), Advanced Medical Optics (AMO), Johnson & Johnson, HSBC, Ranbaxy Laboratories Limited, RFCL, Geologistics India Ltd., limited, Pajas Infopath, KMPL, SGS, Advent Chembio, and Godrej & Boyce Mfg. Co. Ltd. He also served as the Director on the board of the Bank of India (NZ) Limited during 2012-2017.